Tandem Diabetes Care
TNDM
TNDM
303 hedge funds and large institutions have $5.75B invested in Tandem Diabetes Care in 2021 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 109 increasing their positions, 94 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more capital invested
Capital invested by funds: $5.08B → $5.75B (+$669M)
4% more funds holding
Funds holding: 290 → 303 (+13)
2.17% more ownership
Funds ownership: 92.07% → 94.25% (+2.2%)
Holders
303
Holding in Top 10
5
Calls
$86.1M
Puts
$34.4M
Top Buyers
| 1 | +$87.3M | |
| 2 | +$79.2M | |
| 3 | +$74.1M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$44M |
| 5 |
State Street
Boston,
Massachusetts
|
+$30.9M |
Top Sellers
| 1 | -$64.7M | |
| 2 | -$54.3M | |
| 3 | -$30.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$27.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$22.6M |